| Pharmacokinetics of the new hepatitis C virus NS3 protease inhibitor narlaprevir following single-dose use with or without ritonavir in patients with liver cirrhosis V Isakov, D Koloda, N Tikhonova, T Kikalishvili, E Krasavina, K Lekishvili, ... Antimicrobial Agents and Chemotherapy 60 (12), 7098-7104, 2016 | 31 | 2016 |
| Combined therapy of arterial hypertension with triple fixed-dose combination of amlodipine/indapamide/perindopril arginine in real clinical practice: the organization and the … ZD Kobalava, EA Troitskaya, VV Tolkacheva Kardiologiia 58 (9), 21-30, 2018 | 20 | 2018 |
| Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease. VT Ivashkin, MV Maevskaya, ZD Kobalava, YP Uspenskiy, JA Fominih, ... Minerva Gastroenterologica e Dietologica 64 (3), 208-219, 2018 | 19 | 2018 |
| Integral assessment of congestion in patients with acute decompensated heart failure ZD Kobalava, VV Tolkacheva, BK Sarlykov, FE Cabello, M Bayarsaikhan, ... Russian Journal of Cardiology 27 (2), 4799, 2022 | 10 | 2022 |
| Изучение биоэквивалентности препаратов эзетимиба у здоровых добровольцев после однократного приема натощак ВВ Толкачева, ИП Малая, НХ Багманова, ЖД Кобалава Consilium Medicum 21 (1), 87-91, 2019 | 10 | 2019 |
| Uric acid-a marker and/or a new risk factor for cardiovascular complications JD Kobalava, VV Tolkacheva, JL Karaulova Russian Journal of Medicine 10, 431-6, 2002 | 8 | 2002 |
| Нарушения углеводного обмена у больных артериальной гипертонией; клинико-генетические детерминанты и фармакодинамические эффекты метформина и моксонидина ВВ Толкачева [Рос. ун-т дружбы народов], 2004 | 6 | 2004 |
| Effect of Mexidol on the quality of life and functional status of patients with chronic cerebral ischemia and chronic heart failure with reduced left ventricular ejection fraction VV Tolkacheva, ER Kazakhmedov, SA Galochkin, AV Shchulkin Кардиология и сердечно-сосудистая хирургия, 2021 | 5 | 2021 |
| Effects of mexidol in patients with chronic brain ischemia and chronic heart failure (II-III functional class) A Shchulkin, E Kazakhmedov, S Galochkin, V Tolkacheva, Z Kobalava Kardiol. I Serdechno-Sosud. Khirurgiya 13, 427-434, 2020 | 5 | 2020 |
| PP. LB01. 25: PHARMACOKINETIC PARAMETERS OF FIMASARTAN IN RUSSIAN PATIENTS WITH ARTERIAL HYPERTENSION Z Kobalava, E Korneva, V Tolkacheva, Y Kotovskaya, M Samsonov, ... Journal of Hypertension 33, e259-e260, 2015 | 5 | 2015 |
| Состояние углеводного обмена и трансформация предиабета в сахарный диабет тип 2 в зависимости от метода диагностики у пациентов с артериальной гипертензией высокого сердечно … ВВ Толкачева, СВ Виллевальде, ЖД Кобалава Артериальная гипертензия 18 (2), 83-95, 2012 | 5 | 2012 |
| Распространенность и клинические ассоциации дефицита железа у пациентов с декомпенсированной сердечной недостаточностью в зависимости от используемых диагностических критериев … ЖД Кобалава, АА Лапшин, ВВ Толкачева, СА Галочкин Терапевтический архив 94 (7), 844-849, 2022 | 3 | 2022 |
| Prognostic value of integral assessment of congestion in patients hospitalized with acute decompensated chronic heart failure: A single center study ZD Kobalava, VV Tolkacheva, FEC Montoya, BK Sarlykov, M Al-Jarallah, ... Annals of Clinical Cardiology 4 (2), 77-84, 2022 | 2 | 2022 |
| Фармакокинетика фимасартана-нового представителя класса блокаторов АТ1-рецепторов к ангиотензину II в российской популяции ЖД Кобалава, ЮВ Котовская, ВВ Толкачева, ЕВ Корнева, ... Артериальная гипертензия 22 (3), 309-315, 2016 | 2 | 2016 |
| Uric acid–the key component of “cardio-reno-metabolic continuum” ZD Kobalava, YV Kotovskaya, VV Tolkacheva, AS Milto Cardiovascular Therapy and Prevention 7 (4), 95-100, 2008 | 2 | 2008 |
| Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension K ZhD, VV Tolkacheva, IV Ignat'ev, MG Glezer, AI Kuzin, K IuA, ... Terapevticheskii Arkhiv 77 (1), 46-51, 2005 | 2 | 2005 |
| Prevalence of heart failure among hospitalized patient with T2D: results of a prospective observational multicenter study (CREDO) MB Antsiferov, ZD Kobalava, TY Demidova, TN Markova, VV Tolkacheva, ... Diabetes mellitus 27 (1), 4-14, 2024 | 1 | 2024 |
| Effectiveness of buffered acetylsalicylic acid compared to other drugs in diseases patients in clinical practice: results of the CARDINAL observational retrospective study ZD Kobalava, VV Tolkacheva, AN Kaftanov, DV Gavrilov Russian Journal of Cardiology 28 (12), 5709, 2023 | 1 | 2023 |
| Effects and clinical outcomes of early initiation of sacubitril/valsartan in patients with chronic heart failure with a low ejection fraction ZD Kobalava, SA Galochkin, VV Tolkacheva, NK Bagmanova RUDN Journal of Medicine 24 (2), 125-134, 2020 | 1 | 2020 |
| Fixed-dose combination of amlodipine/indapamide/perindopril arginine—a rational and safe choice for blood pressure control in actual clinical setting: data of an observational … JD Kobalava, VV Tolkacheva, EA Troitskaya, IA Kolesnikova, MA Markova Russian Journal of Cardiology 25 (6), 3805, 2020 | 1 | 2020 |
